Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bourdon V, 2002, Genomic and expression analysis of the 12p11‐p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes, Cancer Res, 62, 6218
Chatterjee A, 2001, Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: Occurrence of allelic deletions in precancerous lesions, Cancer Res, 61, 2119
Mitra AB, 1994, Allelotype analysis of cervical carcinoma, Cancer Res, 54, 4481
Mitra AB, 1994, ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix, Cancer Res, 54, 637
Mullokandov MR, 1996, Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human papilloma virus tumor status, Cancer Res, 56, 197
Pulido HA, 2000, Identification of a 6‐cM minimal deletion at 11q23.1–23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer, Cancer Res, 60, 6677
Rader JS, 1996, Allelotyping of all chromosomal arms in invasive cervical cancer, Oncogene, 13, 2737
Redon R, 2002, Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer, Cancer Res, 62, 6211